Corporate Profile for MONTEGEN, dated June 28, 2002.

Business Editors

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-

Published Date:   June 28, 2002

Company Name:     MONTEGEN

Address:          540 Beverly Court - Suite 1
                  Tallahassee, FL  32301

Main Telephone
 Number:          850-561-0604

Internet Home
 Page Address
  (URL)           http://www.montegen.com

Chief Executive
 Officer:         Pier Carlo Montecucchi

Chief Financial
 Officer:         Angela Sabella

Investor Relations
 Contact:
 Business number: 850-561-0604
 E-mail address:  [e-mail]

Public Relations
 Contact:
 Business number: 850-561-0604
 E-mail address:  [e-mail]

Industry:         Biotechnology

Trading Symbol/
 Exchange:

Market Makers: (if public)


Company description: MONTEGEN

Address: in Italy: via G. Dezza n. 24 - 20144 Milano

In USA: 540 Beverly Court, Suite 1 - Tallahassee, FL 32301

Telephone number:
 in Italy: 39 0248007301
 in USA: 850/561-0604

International phone number (011-39) 340/544-1926 (from U.S.A.)

Fax Number:
 in Italy: 39 0248005995

Company description: MONTEGEN, as business interpreter, is a private agile enterprise that provides integrated business solutions in the biotech industry sector, (i) by offering technical consultation, (ii) by providing practical support for business development, business investigations, e-commerce applications, market research, product development and commercialization, technology scouting. With reference to the increasingly intimate contact between science and business, MONTEGEN offers also a valid support to scientists and academic institutions for the commercialization of valuable technologies (still at an embryonic level), facilitating the connection among concept idea, development, production and marketing.

MONTEGEN has recently signed a commercial collaboration with the company DGS International. (Milan, Italy), for the development of clinical trials in U.S. for two new medical devices:

(i) a pin for oral implantoprosthesis (with the revolutionary

self-fixing system in different sizes that can be inserted

also into

particularly atrophic regions)

(ii) a total anatomic hip prosthesis (that can be used without the

removal of the femur's head).

The prostheses, object of the inventions, have been realized thanks to innovatory ideas and with characteristics in accordance with the receiver needs, the physiological structures, the technological aspects of metallurgy, the laws of mechanics (with a special regard for statics, dynamics and tribology). A comparison of these products with those already on the market is reported in details on the Internet ( http://www.montegen.com ).

The agreements with the companies TALENT s.r.l. (Trieste, Italy), and with MAX Engineering (CA, USA) cover the development / commercialization of the following products:

(i) the Multicompartment Immobilized Enzyme Reactor (M.I.E.R.,

for protein characterization)

(ii) a multifunctional liquid sensor, respectively.

For the biopharmaceutical processing, MONTEGEN has signed a commercial distribution agreement with the company METALCOOP (Vibo Valentia, Italy) for the design, manufacture, assembly and installation of pressure vessels, heat exchangers, steel structures, piping assemblies, turbines and compressor casings and base plates, and air coolers (certification ISO 9001 and certification ASME U).

The headquarters is in Milan (Italy) for the European market. The office in Tallahassee (FL, USA) operates on most routes of the American market. MONTEGEN is a registered service mark.

We are proud to be Section 508 compliant. MONTEGEN participates at the project "Safe Harbor" (http://www.export.org/safeharbor )

For more information, MONTEGEN can be reached by e-mail through its Web site at http://www.montegen.com